Among them, C—C chemokine ligand 21, Secondary lymphoid tissue chemokine (CCL21), exerts antitumor immunity by co-localizing dendritic cells and T cells at the tumor sites [[3], [2]]. This evidence concerns the gene CCL21 and neoplasm.